Should You Hold ORIC Pharmaceuticals Inc (ORIC) Stock Monday Morning?

Monday, October 23, 2023 06:35 AM | InvestorsObserver Analysts

Mentioned in this article

ORIC Pharmaceuticals Inc (ORIC) is higher by Monday morning, with the stock rising 12.90% in pre-market trading to 6.39. ORIC's short-term technical score of 67 indicates that the stock has traded more bullishly over the last month than 67% of stocks on the market. In the Biotechnology industry, which ranks 137 out of 146 industries, the stock ranks higher than 84% of stocks. ORIC Pharmaceuticals Inc has fallen 27.53% over the past month, closing at $7.56 on September 25. During this period of time, the stock fell as low as $5.41 and as high as $8.02. ORIC has an average analyst recommendation of Strong Buy. The company has an average price target of $15.63.

ORIC has an Overall Score of 71. Find out what this means to you and get the rest of the rankings on ORIC!
ORIC Pharmaceuticals Inc has a Long-Term Technical rank of 77. This means that trading over the last 200 trading days has placed the company in the upper half of stocks with 23% of the market scoring higher. In the Biotechnology industry which is number 135 by this metric, ORIC ranks better than 135% of stocks.

Important Dates for Investors in ORIC:

-ORIC Pharmaceuticals Inc is set to release earnings on 2023-11-06. Over the last 12 months, the company has reported EPS of $-2.18. -We do not have a set dividend date for ORIC Pharmaceuticals Inc at this time. Click Here To Get The Full Report on ORIC Pharmaceuticals Inc (ORIC)

Share this article: